Primary Immune thrombocytopenia (ITP): Romiplate is indicated for the treatment of primary immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins) (see Dosage & Administration and Pharmacology: Pharmacodynamics under Actions).
Aplastic anaemia: Romiplate is indicated for adults with moderate to severe aplastic anaemia refractory to conventional therapies.